Heads of State and global leaders came together at the G20 Leaders’ Summit held in Hamburg, Germany on 7–8 July 2017. Dr Tedros Adhanom Ghebreyesus, WHO Director-General, led the WHO delegation participating in the G20 Summit. He met with heads of state and other high-level delegates to advocate for WHO priorities in global health. The 2017 G20 meeting for the first time included a comprehensive health track among its deliberations. The G20 Leaders’ Declaration – “Shaping an interconnected world” highlighted the importance of combatting antimicrobial resistance (AMR) including tuberculosis (TB) within its section on “Building Resilience” (see page 8-9),Specifically, TB was prioritized among other priority bacterial pathogens identified by WHO for which there is a critical need for fostering R&D. There was a call for a new international R&D Collaboration Hub to maximize the impact of existing and new antimicrobial basic and clinical research initiatives as well as product development. The Declaration also supported WHO´s central coordinating role in global health and response to health emergencies.
G20 Leaders’ Declaration is available here.